A catalytically inactive mutant of the deubiquitylase YOD-1 enhances antigen cross-presentation

作者：Sehrawat Sharvan; Koenig Paul Albert; Kirak Oktay; Schlieker Christian; Fankhauser Manuel; Ploegh Hidde L^*

来源：Blood, 2013, 121(7): 1145-1156.

DOI：10.1182/blood-2012-08-447409

Antigen presenting cells (APCs) that express a catalytically inactive version of the deubiquitylase YOD1 (YOD1-C160S) present exogenous antigens more efficiently to CD8(+) T cells, both in vitro and in vivo. Compared with controls, immunization of YOD1-C160S mice led to greater expansion of specific CD8(+) T cells and showed improved control of infection with a recombinant gamma-herpes virus, MHV-68, engineered to express SIINFEKL peptide, the ligand for the ovalbumin-specific TCR transgenic OT-I cells. Enhanced expansion of specific CD8(+) T cells was likewise observed on infection of YOD1-C160S mice with a recombinant influenza A virus expressing SIINFEKL. YOD1-C160S APCs retained antigen longer than did control APCs. Enhanced cross-presentation by YOD1-C160S APCs was transporter associated with antigen processing (TAP1)-independent but sensitive to inclusion of inhibitors of acidification and of the proteasome. The activity of deubiquitylating enzymes may thus help control antigen-specific CD8(+) T-cell responses during immunization. (Blood. 2013; 121(7): 1145-1156)

• 出版日期2013-2-14